Abstract
A series of phosphine–Pt2+-catalysts is reported, which enable the oxidative cascade cyclization of poly-alkene substrates. When the terminus is appropriately arranged and a catalyst reoxidation mediator is included, several polycyclic all carbon skeletons can be obtained. In one example, a chiral P2Pt+2 catalyst provides up to 79% ee.
The cation-olefin cascade cyclization of polyenes with a terminating alkene are considerably more difficult than the analogous cyclization containing a protic terminus (OH, NH, etc.),1e.g. eqn (1).2 Terminating group effects on cyclization efficiency have been long known and pioneers like Johnson,3 van Tamelen4 and Corey5 used these effects to benefit in the development of increasingly efficient synthetic methodologies.6 Thus far, catalytic methodologies, especially those able to exercise absolute stereocontrol have been unable to overcome the challenge of a simple alkene terminating group.5,7 H-bond activation of terminating OH groups by a base leads to a nearly barrierless cascade (once in the correct conformation), which additionally benefits from an enhanced thermodynamic driving force.8 Since alkene termini do not become acidic until the cation is nearly fully formed, H-bond assistance is lost in these cases and higher energy intermediates are required with a concominant decrease in cyclization rate. Enzymatic cyclizations can overcome these inherent features by the strategic positioning of bases or arenes for stabilizing cation-π interactions,9 but fully synthetic versions must rely on other means.
![]() |
(1) |
We have recently reported that electrophilic (triphos)Pt-dications can indeed initiate the cation-olefin cascade cyclization of all-alkene substrates,10 though rates suffered considerably versus analogs with protic termini (e.g. eqn (2)). In this contribution we extend these initial observations, which were stoichiometric in Pt(ii), to ligand–metal combinations that are amenable to catalysis and with chiral ligand variants, asymmetric catalysis.
![]() |
(2) |
Our earliest studies sought to simply apply the conditions optimized for reactions like eqn (1), but these led to poor rates and conversions that eventually ceased prior to complete consumption of starting material. Based on unpublished observations that show slow hydride abstraction to be the cause of catalyst deactivation, optimization efforts sought to improve the hydride abstraction step of the proposed mechanism by the addition of Ph3C+ (Tr+) to the catalyst formulation (Scheme 1). Under these conditions improved conversions were possible. These conditions were utilized to search for beneficial ligand effects. A screen of common diphosphine ligands showed that BINAP provides a catalyst capable of generating 81% 2 at 90% conversion; the mass balance were minor amounts of unidentified isomeric products.
Scheme 1.
Proposed mechanism.
A second round of optimization on the BINAP-based catalyst, paying particular attention to the seemingly key hydride abstraction step was undertaken. In addition to TrOMe, the 4-methoxy variant, resin based versions of both and recently reported acetal-based variants were tested.11 While dimethoxy methane (and benzaldehyde) function well with protic terminators, they led to reaction rates that were half that of TrOMe. The use of TrOMe plus an equimolar quantity (to Pt) of TrBF4 ensured that the putative P2Pt–H+ intermediate reacted with at least a 2-fold excess of Tr+. More than any other modification of the reaction conditions, extra Tr+ was most beneficial. Increasing TrBF4 up to a 5-fold excess (vs. Pt) was optimum and 100% conversion of 1 was possible (Table 1).12
Table 1.
Screen of hydride abstraction agents
| ||
|---|---|---|
| Entry | Hydride abstractor | 2a (%) |
| 1 | 200% TrOMe | 17 |
| 2 | 300% TrOMe resin | 14 |
| 3 | 200% 2(4-Meo)TrOMe | 7 |
| 4 | 300% (4-MeO)TrOMe resin | 8 |
| 5 | 200% TrOMe, 10% TrBF4 | 44 |
| 6 | 160% TrOMe, 20% TrBF4 | 65 |
| 7 | 100% TrOMe, 50% TrBF4 | 90b |
| 8 | 160% (MeO)2CH2, 10% [Ph2NH2][BF4] | 18 |
Determined by GC analysis. Remainder is unreacted 1.
15% Isolated yield.
With a set of reaction conditions capable of efficiently converting 1 to 2 (90%) in hand, a survey of alternative poly-ene structures was undertaken (Table 2). Tetra-ene 3 efficiently generated a single stereoisomer of 4 as the predominant product of the oxidative cyclization (entry 1). Previous studies have shown7 that the nucleophilicity of the terminating alkene13 is a good predictor of the reaction time. Poly-ene substrates with more nucleophilic terminating alkenes were thus tested, though their cyclizations met with mixed success. Some cyclized effectively (e.g. entry 2) while others displayed more complex behavior. The styrene terminated 5 proved to be an excellent substrate, providing a product whose mass balance was 90% bicyclic diene 6. In contrast, the para-methoxy substituted variant, 15, preferentially isomerizes to the tri-substituted (and unreactive) alkene 16 (eqn (3)).
![]() |
(3) |
Table 2.
Polyene cyclizations catalyzed by (BINAP)Pt2+
| Entrya | Substrate | Product | Timeb (h) | Conversionc (isolated yield) |
|---|---|---|---|---|
| 1 |
|
|
36 | 89d (14) |
| 2 |
|
|
36 | 90d (19) |
| 3 |
|
|
16 | 33e (9) |
|
|
|||
| 4 | 9 R = H | 10 | 24 | 50f (5) |
| 5 | 11 R = OMe | 12 | 8 | 55f (5) |
| 6 |
|
|
16 | 32g (4) |
Reaction conditions: 100 μmol substrate, 10 μmol (BINAP)PtI2, 22.5 μmol AgBF4, 30 μmol NCC6F5, 30 μmol Ph2NH, 100 μmol TrOMe, 50 μmol TrBF4, and 0.6 mL EtNO2.
Reaction time determined by consumption of starting material (GC analysis).
GC conversions report mass balance of desired product relative to all other isomers and starting material. Spectroscopically pure (≥95%) products could be obtained, though difficulties in hydrocarbon separation considerably lowered the isolated yields.
Mass balance composed of a single undetermined product isomer.
Mass balance composed of 3 products from side reactivity between starting material and Tr+ in a 2.1: 1 : 1.9 ratio.
Mass balance composed of corresponding naphthyl product 15/16.
Mass balance composed of 5 monocyclized product isomers in a 1.3 : 2.1 : 1.3 : 1 : 2.2 ratio.
The low selectivities for the dihydronaphthyl substrates 9 and 11 are due to a series of side reactions (Scheme 2), including direct oxidization by Tr+/TrOMe of the dihydro naphthyl to a naphthyl analog, which was surprisingly unreactive to follow up cyclization. Compounds 10 and 12 were also prone to rearrangement under the acidic conditions. This rearrangement could be accelerated by the deliberate addition of acid (MeSO3H). Aryl terminating groups have provided mixed success with other cyclization techniques.14 In the present case, 13 provided numerous side products, despite having the stoichiometric cyclizations with (PPP)Pt+2 being selective for a single product.15
Scheme 2.
Side reactions of dihydronaphthyl substrate and product.
The clean conversion of 5 to diene 6 suggests that the putative carbenium ion intermediate A may generate the product under kinetic or thermodynamic control. DFT calculations16 on the decalin (deplatinated) products indicated that the observed product was favored by 4.0 kcal mol–1 over its alternative styrene isomer. Attempts to manipulate the direction of this elimination through methyl substitutions on the carbon skeleton were unsuccessful. When the 8,8-dimethyl analog of 5 was examined (Scheme 3), no reaction was observed, either with the standard P2Pt+2 or the (triphos)Pt+2 initiators. An analysis of the low energy conformers of 8,8-Me2-5 suggested that gem-dimethyl groups deconjugate the styrene and thus reduce its nucleophilicity and the concomitant stability of the benzyl cation intermediate.17
Scheme 3.
Cation intermediate for the conversion of 5 to 6.
The ability to catalyze the cation-olefin cyclization under the control of a P2Pt+2-catalyst suggests the reasonableness of enantioselective variants. As shown in Table 3, the optimum conditions could be ported to catalysts carrying chiral diphosphine ligands. As before,18 the xylyl-PHANEPHOS derived catalyst provided the optimum enantioselectivities (79% ee), though xylyl-BINAP gave a reasonable compromise between conversion and % ee.
Table 3.
Effect of ligand on enantioselectivity
| |||
|---|---|---|---|
| Entry | Ligand | Conversiona (%) | % eeb |
| 1c | (R)-xylyl-PHANEPHOS | 44 | 79 |
| 2 | (R)-xylyl-MeO-BINAP | 80 | 68 |
| 3 | (R)-xylyl-BINAP | 87 | 67 |
| 4 | (R)-SEGPHOS | 90 | 44 |
Mass balance composed of unreacted starting material.
Determined by chiral GC.
The absolute configuration of 2 is predicted to be as shown by analogy to previously reported work.18
As described herein, the significant challenge of an ionic catalyst-controlled cascade-cyclization of poly-enes can at least partially be solved using P2Pt+2 catalysts. Key to the methodology development has been the realization that fast hydride abstraction from a key Pt–H intermediate is key to catalytic efficiency. To our knowledge these represent a first for a catalytic cascade cyclization of polyenes containing alkene terminating groups. Proof-of-principle enantioselective results are also reported.
Supplementary Material
Footnotes
Electronic supplementary information (ESI) available: Synthesis and characterization of all compounds.
Notes and references
- 1.Pradal A, Chen Q, Faudot dit Bel P, Toullec PY, Michelet V. Synlett. 2012:74–79. [Google Scholar]; Cannon JS, Olson AC, Overman LE, Solomon NS. J. Org. Chem. 2012;77:1961–1973. doi: 10.1021/jo202553a. [DOI] [PMC free article] [PubMed] [Google Scholar]; Sakakura A, Sakuma M, Ishihara K. Org. Lett. 2011;13:3130–3133. doi: 10.1021/ol201032t. [DOI] [PubMed] [Google Scholar]; Toullec PY, Blarre T, Michelet V. Org. Lett. 2009;11:2888–2891. doi: 10.1021/ol900864n. [DOI] [PubMed] [Google Scholar]; Liskin DV, Sibbald PA, Rosewall CF, Michael FE. J. Org. Chem. 2010;75:6294–6296. doi: 10.1021/jo101171g. [DOI] [PubMed] [Google Scholar]; Surendra K, Corey EJ. J. Am. Chem. Soc. 2008;130:8865–8869. doi: 10.1021/ja802730a. [DOI] [PubMed] [Google Scholar]; Nakamura S, Ishihara K, Yamamoto H. J. Am. Chem. Soc. 2000;122:8131–8140. [Google Scholar]
- 2.Koh JH, Gagné MR. Angew. Chem., Int. Ed. 2004;43:3459–3461. doi: 10.1002/anie.200453913. [DOI] [PubMed] [Google Scholar]; Koh JH, Mascarenhas C, Gagné MR. Tetrahedron. 2004;60:7405–7410. [Google Scholar]
- 3.Johnson WS, Daub GW, Lyle TA, Niwa M. J. Am. Chem. Soc. 1980;102:7800–7802. [Google Scholar]; Johnson WS, Bunes LA. J. Am. Chem. Soc. 1976;98:5597–5602. [Google Scholar]; Carney RL, Johnson WS. J. Am. Chem. Soc. 1974;96:2549–2556. [Google Scholar]; Johnson WS. Acc. Chem. Res. 1967;1:1–8. [Google Scholar]
- 4.Van Tamelen EE, Hwu JR. J. Am. Chem. Soc. 1983;105:2490–2491. [Google Scholar]; Van Tamelen EE. Acc. Chem. Res. 1975;8:152–158. [Google Scholar]
- 5.Surendra K, Corey EJ. J. Am. Chem. Soc. 2012;134:11992–11994. doi: 10.1021/ja305851h. [DOI] [PubMed] [Google Scholar]; Surendra K, Qiu W, Corey EJ. J. Am. Chem. Soc. 2011;133:9724–9726. doi: 10.1021/ja204142n. [DOI] [PubMed] [Google Scholar]
- 6.Kotora M, Hessler F, Eignerová B. Eur. J. Org. Chem. 2012:29–42. [Google Scholar]; Yoder RA, Johnston JN. Chem. Rev. 2005;105:4730–4756. doi: 10.1021/cr040623l. [DOI] [PMC free article] [PubMed] [Google Scholar]; Bartlett PA. In: Asymmetric Synthesis. Morrison JD, editor. Vol. 3. Academic Press; New York: 1984. pp. 341–454. [Google Scholar]
- 7.Godeau J, Fontaine-Vive F, Antoniotti S, Duñach E. Chem.–Eur. J. 2012;18:16815–16822. doi: 10.1002/chem.201202263. [DOI] [PubMed] [Google Scholar]; Vece V, Hassen KBH, Antoniotti S, Duñach E. Tetrahedron Lett. 2012;53:5102–5105. [Google Scholar]; Takao H, Wakabayashi A, Takahashi K, Imagawa H, Sugihara T, Nishizawa M. Tetrahedron Lett. 2004;45:1079–1082. [Google Scholar]
- 8.Nowroozi-Isfahani T, Musaev DG, Morokuma K, Gagné MR. Organometallics. 2007;26:2540–2549. [Google Scholar]; Jenson C, Jorgensen WL. J. Am. Chem. Soc. 1997;119:10846–10854. [Google Scholar]; Metivier P, Gushurst AJ, Jorgensen WL. J. Org. Chem. 1987;52:3724–3738. [Google Scholar]
- 9.Christianson DW. Chem. Rev. 2006;106:3412–3442. doi: 10.1021/cr050286w. [DOI] [PubMed] [Google Scholar]; Rajamani R, Gao J. J. Am. Chem. Soc. 2003;125:12768–12781. doi: 10.1021/ja0371799. [DOI] [PubMed] [Google Scholar]; Hoshino T, Sato T. Chem. Commun. 2002:291–301. doi: 10.1039/b108995c. [DOI] [PubMed] [Google Scholar]; Wendt KU, Schulz GE, Corey EJ, Liu DR. Angew. Chem., Int. Ed. 2000;39:2812–2833. [PubMed] [Google Scholar]
- 10.Sokol JG, Korapala CS, White PS, Becker JJ, Gagné MR. Angew. Chem., Int. Ed. 2011;50:5658–5661. doi: 10.1002/anie.201100463. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Cochrane NA, Brookhart MS, Gagné MR. Organometallics. 2011;30:2457–2460. doi: 10.1021/om2001958. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Screens of AgX (X = PF6, SbF6, OTf) and modified nitriles (tBuCN and 3,5-(CF3)2C6H3CN) revealed few significant effects on rate or conversion (see ESI†). The nitrile acts as a labile ligand and is capable of filling open coordination sites.
- 13.Mayr H, Kempf B, Ofial AR. Acc. Chem. Res. 2003;36:66–77. doi: 10.1021/ar020094c. [DOI] [PubMed] [Google Scholar]
- 14.Li B, Lai Y-C, Zhao Y, Wong Y-H, Shen Z-L, Loh T-P. Angew. Chem., Int. Ed. 2012;51:10619–10623. doi: 10.1002/anie.201205981. [DOI] [PubMed] [Google Scholar]; Schafroth MA, Sarlah D, Krautwald S, Carreira EM. J. Am. Chem. Soc. 2012;134:20276–20278. doi: 10.1021/ja310386m. [DOI] [PubMed] [Google Scholar]; Surendra K, Corey EJ. J. Am. Chem. Soc. 2008;130:8865–8869. doi: 10.1021/ja802730a. [DOI] [PubMed] [Google Scholar]; Imagawa H, Iyenaga T, Nishizawa M. Org. Lett. 2005;7:451–453. doi: 10.1021/ol047472t. [DOI] [PubMed] [Google Scholar]
- 15.Kumazawa K, Ishihara K, Yamamoto H. Org. Lett. 2004;6:2551–2554. doi: 10.1021/ol049126h. [DOI] [PubMed] [Google Scholar]; Ishihara K, Ishibashi H, Yamamoto H. J. Am. Chem. Soc. 2001;123:1505–1506. [Google Scholar]
- 16.DFT B3LYP/6-31G* calculations on the deplatinated analogs, MacSpartan 2008 calculations; energies were uncorrected.
- 17.Cucciolito ME, D'Amora A, Vitagliano A. Organometallics. 2010;29:5878–5884. [Google Scholar]; Cucciolito ME, D'Amora A, Tuzi A, Vitagliano A. Organometallics. 2007;26:5216–5223. [Google Scholar]; Liu C, Bender CF, Han X, Widenhoefer RA. Chem. Commun. 2007:3607–3618. doi: 10.1039/b615698c. [DOI] [PubMed] [Google Scholar]; Wang X, Widenhoefer RA. Chem. Commun. 2004:660–661. doi: 10.1039/b316734h. [DOI] [PubMed] [Google Scholar]
- 18.Mullen CA, Campbell AN, Gagné MR. Angew. Chem., Int. Ed. 2008;47:6011–6014. doi: 10.1002/anie.200801423. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.






